SIRT1/2 inhibitors (MethylGene/Celgene)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameSIRT1/2 inhibitors (MethylGene/Celgene)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNAD-dependent protein deacetylase sirtuin-2 inhibitorsNAD-dependent deacetylase sirtuin 1 inhibitors
TargetsNAD-dependent protein deacetylase sirtuin-2NAD-dependent deacetylase sirtuin 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMethylgene Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCelgene CorpMethylgene Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A